|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2589669 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13152518.0 |
| Date of filing the European patent application | 2011-04-11 | |
| (97) | Date of publication of the European application | 2013-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 323502 P | 2010-04-13 | US |
| (72) |
Chu, Tom, US
Essioux, Laurent, FR
Germer, Soren, US
Lopatin, Uri, US
Shulman, Nancy, US
Thommes, James, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | Single nucleotide polymorphisms that predict HCV treatment outcomes |
| Single nucleotide polymorphisms that predict HCV treatment outcomes |